140 related articles for article (PubMed ID: 21084822)
21. [A successfully treated case of type 4 gastric cancer with intraperitoneal free cancer cells undergoing a curative resection followed by neoadjuvant chemotherapy with S-1 plus cisplatin].
Koizumi S; Iwasaki Y; Ohashi M; Iwanaga T; Ohinata R; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D; Tateishi Y
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2464-6. PubMed ID: 21224607
[TBL] [Abstract][Full Text] [Related]
22. [Three cases of gastric cancer treated by S-1 combined with docetaxel in place of cisplatin].
Ganno H; Watayo Y; Amagasa H; Ohhara T; Hataji K; Kawasaki N; Kurokawa T; Ami K; Fukuda A; Nagahama T; Ando M; Arai K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2458-60. PubMed ID: 21224605
[TBL] [Abstract][Full Text] [Related]
23. A phase II study of modified docetaxel, cisplatin, and S-1 (mDCS) chemotherapy for unresectable advanced gastric cancer.
Uemura N; Kikuchi S; Sato Y; Ohnuma H; Okamoto K; Miyamoto H; Hirakawa M; Sagawa T; Fujikawa K; Takahashi Y; Okuda T; Minami S; Takahashi M; Okamoto T; Takada K; Miyanisi K; Takayama T; Kato J
Cancer Chemother Pharmacol; 2017 Oct; 80(4):707-713. PubMed ID: 28849257
[TBL] [Abstract][Full Text] [Related]
24. [Two cases of advanced gastric cancer with peritoneal dissemination, and Virchow's metastases successfully treated by combination therapy of S-1 and docetaxel].
Kubo H; Kijima T; Kitahara M; Tada K; Miyahara M; Hasegawa H
Gan To Kagaku Ryoho; 2010 Jan; 37(1):147-50. PubMed ID: 20087051
[TBL] [Abstract][Full Text] [Related]
25. A comparison of multimodality treatment: two and four courses of neoadjuvant chemotherapy using S-1/CDDP or S-1/CDDP/docetaxel followed by surgery and S-1 adjuvant chemotherapy for macroscopically resectable serosa-positive gastric cancer: a randomized phase II trial (COMPASS-D trial).
Yoshikawa T; Taguri M; Sakuramoto S; Kunisaki C; Fukunaga T; Ito S; Cho H; Tanabe K; Nishikawa K; Matsui T; Morita S; Tsuburaya A
Jpn J Clin Oncol; 2012 Jan; 42(1):74-7. PubMed ID: 22102736
[TBL] [Abstract][Full Text] [Related]
26. Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer.
Mieno H; Yamashita K; Hosoda K; Moriya H; Higuchi K; Azuma M; Komori S; Yoshida T; Tanabe S; Koizumi W; Katada N; Watanabe M
Surg Today; 2017 Oct; 47(10):1249-1258. PubMed ID: 28365892
[TBL] [Abstract][Full Text] [Related]
27. Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer.
Yoshikawa T; Morita S; Tanabe K; Nishikawa K; Ito Y; Matsui T; Fujitani K; Kimura Y; Fujita J; Aoyama T; Hayashi T; Cho H; Tsuburaya A; Miyashita Y; Sakamoto J
Eur J Cancer; 2016 Jul; 62():103-11. PubMed ID: 27244537
[TBL] [Abstract][Full Text] [Related]
28. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
Inoue K; Nakane Y; Kogire M; Fujitani K; Kimura Y; Imamura H; Tamura S; Okano S; Kwon AH; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
Eur J Surg Oncol; 2012 Feb; 38(2):143-9. PubMed ID: 22154885
[TBL] [Abstract][Full Text] [Related]
29. Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy.
Tamura S; Fujitani K; Kimura Y; Tsuji T; Matsuyama J; Iijima S; Imamura H; Inoue K; Kobayashi K; Kurokawa Y; Furukawa H;
Oncology; 2011; 80(5-6):296-300. PubMed ID: 21778769
[TBL] [Abstract][Full Text] [Related]
30. S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial.
Lee CK; Jung M; Kim HS; Jung I; Shin DB; Kang SY; Zang DY; Kim KH; Lee MH; Kim BS; Lee KH; Cheong JH; Hyung WJ; Noh SH; Chung HC; Rha SY
Cancer Res Treat; 2019 Jan; 51(1):1-11. PubMed ID: 29397659
[TBL] [Abstract][Full Text] [Related]
31. [A case of AGC with pCR after preoperative chemotherapy including S-1 plus cisplatin].
Funaki H; Ohnishi T; Ohno Y; Tomita Y; Hosokawa K; Yokoi M; Yoshitani S; Kinami S; Omote K; Ueda N; Nakano Y; Kosaka T
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2430-2. PubMed ID: 21224596
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of docetaxel and S-1 (DS) as neoadjuvant chemotherapy for clinical stage III resectable gastric cancer.
Oki E; Emi Y; Kusumoto T; Sakaguchi Y; Yamamoto M; Sadanaga N; Shimokawa M; Yamanaka T; Saeki H; Morita M; Takahashi I; Hirabayashi N; Sakai K; Orita H; Aishima S; Kakeji Y; Yamaguchi K; Yoshida K; Baba H; Maehara Y
Ann Surg Oncol; 2014 Jul; 21(7):2340-6. PubMed ID: 24604583
[TBL] [Abstract][Full Text] [Related]
33. [A Case of Unresectable Advanced Gastric Cancer Treated by Seven Courses of Chemotherapy with Docetaxel, Cisplatin, and S-1Followed by Conversion Surgery Achieved Five Year Relapse Free Survival].
Nakajima T; Cho H; Okubo Y; Kano K; Maezawa Y; Ikeda K; Yamada T; Ogata T; Yoshikawa T
Gan To Kagaku Ryoho; 2018 Apr; 45(4):755-757. PubMed ID: 29650858
[TBL] [Abstract][Full Text] [Related]
34. [Three scirrhous gastric cancer cases with CY negativity in second-look staging laparoscopy after chemotherapy to whom curative surgery was carried out].
Kishimoto T; Imamura H; Kawabata R; Fukunaga M; Ohzato H; Furukawa H
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2306-8. PubMed ID: 20037404
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant chemotherapy combining docetaxel, cisplatin and S-1 in gastric cancer with para-aortic lymph node metastases: report of five cases.
Fushida S; Fujimura T; Oyama K; Kinoshita J; Fujita H; Ninomiya I; Ohta T
Hepatogastroenterology; 2010; 57(104):1650-4. PubMed ID: 21443137
[TBL] [Abstract][Full Text] [Related]
36. [Adjuvant chemotherapy with S-1 plus docetaxel for highly advanced gastric cancer patients].
Egawa T; Kemmochi T; Irino T; Mihara K; Okamura A; Etoh E; Inaba Y; Segami K; Ito Y; Nagashima A
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2310-2. PubMed ID: 23268060
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of type four gastric cancer in our institution].
Ito M; Takayama T; Matsumoto S; Wakatsuki K; Tanaka T; Migita K; Kunishige T; Nakade H; Nakajima Y
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2242-4. PubMed ID: 25731483
[TBL] [Abstract][Full Text] [Related]
38. [A Case of Advanced Gastric Cancer Treated with Curative Resection after Preoperative Secondary Chemotherapy with Irinotecan after Primary Chemotherapy with Docetaxel, Cisplatin, and S-1].
Kobayashi D; Takase T; Hanaki T; Ichikawa T; Masubuchi M; Deguchi T; Shibata A; Yaguchi T
Gan To Kagaku Ryoho; 2018 Jun; 45(6):969-971. PubMed ID: 30026424
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer.
Kosaka T; Akiyama H; Miyamoto H; Sato S; Tanaka Y; Sato K; Kunisaki C; Endo I
Cancer Chemother Pharmacol; 2019 Jun; 83(6):1047-1055. PubMed ID: 30911769
[TBL] [Abstract][Full Text] [Related]
40. A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival.
Kim YW; Kim MJ; Ryu KW; Lim HS; Lee JH; Kong SY; Lee JS; Choi IJ; Kim CG; Lee JY; Cho SJ; Kook MC; Park YI; Kim SK; Park SR
Gastric Cancer; 2016 Apr; 19(2):586-596. PubMed ID: 25851942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
